Antibody titer-increasing agent using lactic acid bacterium
The present invention addresses the problem of providing an antibody titer-increasing agent, such as an adjuvant, capable of sustaining an effect achieved by, for example, vaccination, which is an antibody titer-increasing agent such as an adjuvant that is safe, convenient and economical and can be easily taken irrespective of age, and a method for manufacturing the same. A method for increasing an antibody titer and a method for enhancing the effect of a vaccine, each method comprising using Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 or a culture thereof; and an antibody titer-increasing agent such as an adjuvant that comprises Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 or a culture thereof.
1. An adjuvant for a vaccine, comprising a package containing 100 to 200 g or 100 to 200 mL of a culture obtained by anaerobically culturing a medium containing an ingredient selected from raw milk (unpasteurized milk), pasteurized milk, full fat condensed milk, whole milk powder, skimmed milk, skimmed condensed milk, skimmed milk powder, milk protein concentrate (MPC), whey, whey powder, desalted whey, desalted whey powder, whey protein concentrate (WPC), whey protein isolate (WPI), α-lactoalbumin (α-La), β-lactoglobulin (β-Lg), casein, sodium caseinate, calcium caseinate, cream, butter, saccharides (including lactose), and a yeast extract with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1(Deposit Accession Number: FERM BP-10741) and Streptococcus thermophilus at a temperature of 35° C. to 45° C. for 2 to 24 hours.
2. The adjuvant according to claim 1 , wherein it is an adjuvant for a vaccine for an infectious disease.
3. The adjuvant according to claim 2 , wherein the infectious disease is influenza.
4. The adjuvant according to claim 1 , wherein it comprises 9×10 7 to 10 12 cfu lactic acid bacteria per package.
5. A method for increasing an antibody titer, the method comprising a subject ingesting or being made to ingest the adjuvant according to claim 1 .
6. The method according to claim 5 , wherein ingestion of 10 to 1000 g or 10 to 1000 mL of the adjuvant per day is continued for at least three weeks.
7. The method according to claim 6 , wherein ingestion of the adjuvant is continued from at least one week before the date of vaccination.
8. A method for increasing an antibody titer, the method comprising administering to a subject the adjuvant according to claim 1 .
9. The method according to claim 8 , wherein administration of 10 to 1000 g or 10 to 1000 mL of the adjuvant per day is continued for at least three weeks.
10. The method according to claim 9 , wherein administration of the adjuvant is continued from at least one week before the date of vaccination.
11. The adjuvant according to claim 1 , wherein the Streptococcus thermophilus is Streptococcus thermophilus OLS3059 (Deposit Accession Number: FERM BP-10740).